Chad Therapeutics Reports Net Loss in 3rd Quarter
- Share via
Chad Therapeutics Inc. in Chatsworth announced a net loss for the third quarter ended Dec. 31 of $683,000 compared with a net loss of $894,000 for the same period the previous year. Revenue decreased slightly to $2.96 million from $2.98 million.
Chad Therapeutics produces and distributes supplementary oxygen systems and devices for the health-care industry.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
